Responses
Extended essay
‘The ethics approval took 20 months on a trial which was meant to help terminally ill cancer patients. In the end we had to send the funding back’: a survey of views on human research ethics reviews
Compose a Response to This Article
Other responses
No responses have been published for this article.
Other content recommended for you
- Implementation of the process of ethical review of improvement activities at the Children 's Hospital at Westmead
- Navigating the maze: ethics approval pathways for intellectual disability research
- Ethics review roulette: what can we learn
- Ethics review of research: in pursuit of proportionality
- Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high - risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high - risk, localised Prostate cancer)
- Problems and development strategies for research ethics committees in China ’s higher education institutions
- Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories
- Oral cannabinoid - rich THC / CBD cannabis extract for secondary prevention of chemotherapy - induced nausea and vomiting: a study protocol for a pilot and definitive randomised double - blind placebo - controlled trial (CannabisCINV)
- Reforming the politics of animal research
- The ESRC research ethics framework and research ethics review at UK universities: rebuilding the Tower of Babel REC by REC